Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9015 |
High Similarity |
NPD3027 |
Phase 3 |
0.8676 |
High Similarity |
NPD1613 |
Approved |
0.8676 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8409 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8382 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD1357 |
Approved |
0.8309 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8271 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8267 |
Intermediate Similarity |
NPD37 |
Approved |
0.8243 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8224 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8224 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8224 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8117 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8015 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7945 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7931 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7888 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7875 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7857 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7852 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7792 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7756 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7746 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7742 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7742 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7737 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.771 |
Intermediate Similarity |
NPD228 |
Approved |
0.7697 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4678 |
Approved |
0.766 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7615 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7597 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7584 |
Intermediate Similarity |
NPD4237 |
Approved |
0.758 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7568 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7519 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7481 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD290 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7397 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7357 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7303 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5773 |
Approved |
0.729 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD291 |
Approved |
0.7284 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3383 |
Approved |
0.723 |
Intermediate Similarity |
NPD5735 |
Approved |
0.723 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.723 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7214 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7203 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7197 |
Intermediate Similarity |
NPD968 |
Approved |
0.7192 |
Intermediate Similarity |
NPD7095 |
Approved |
0.719 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7164 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7164 |
Intermediate Similarity |
NPD556 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6799 |
Approved |
0.716 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7152 |
Intermediate Similarity |
NPD3454 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7114 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD6841 |
Approved |
0.711 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.711 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7107 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7007 |
Discovery |
0.7097 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7093 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7071 |
Intermediate Similarity |
NPD1182 |
Approved |
0.707 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7047 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD5403 |
Approved |
0.702 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6986 |
Remote Similarity |
NPD558 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD7680 |
Approved |
0.6975 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6968 |
Remote Similarity |
NPD4535 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD7526 |
Approved |
0.6962 |
Remote Similarity |
NPD52 |
Approved |
0.6962
|
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |